NIH-funded research R01 grant

COSMIIC tSNIP: a painless, targeted nerve block for chronic knee pain

Official title: COSMIIC tSNIP to Treat Chronic Knee Pain

Funded at Case Western Reserve University · NIH-11346539 · Data updated 2026-11-12

A new, localized light-based treatment aims to temporarily quiet pain signals from the knee to help people with chronic knee pain feel better.

More Chronic Knee Pain research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionCase Western Reserve University
NIH-funded
Lab location1 site (Cleveland, United States)
Project startAugust 1, 2026
Project endJuly 31, 2030
Funding year2026
Award (this year)$3,778,614
NIH project number1R01EB039066-01
Project IDNIH-11346539 on NIH RePORTER

Who could benefit from this research

Could help

Adults with chronic knee pain who could benefit from localized, temporary pain suppression.

Less likely to help

Individuals without chronic knee pain or those seeking systemic (non-local) pain therapies are less likely to benefit.

What this research studies

This project seeks to develop a patient-friendly device that uses light to selectively dampen pain signals from the nerves around the knee, with the goal of providing durable relief without affecting movement or sensation. Researchers will optimize the light delivery parameters and test how well the system blocks small-fiber pain signals in preclinical tissue studies, then design a human-grade implantable option. The work builds on an existing, safe platform that already works for electrical stimulation and sensing in people, adding a new optical component for pain relief. If successful, this approach could lead to a customizable, localized treatment for chronic knee pain that minimizes systemic side effects.

Why it matters

Potential benefit: If successful, patients could experience longer-lasting knee pain relief with fewer systemic risks and fewer daily activity limitations.

How similar studies have gone: Previous work with the COSMIIC platform shows safety and feasibility for neuromodulation; this study extends it with a targeted optical approach.

Where this research is happening

  • Case Western Reserve University
    Cleveland, United States
    Active

Researchers

  • Principal investigator: Moffitt, Michael — Case Western Reserve University
  • Study coordinator: Moffitt, Michael

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.